Z2 Biopharma loading
Insights

Evidence behind better development decisions

Briefings and perspectives on cell line development, upstream processing, technology transfer and the biologics CMC pathway.

Trends

Trends

Why programmes stall, the CMC gap behind FDA rejections, complex formats, scale-up, GMO rules and the BIOSECURE Act.

Read More
Z2 Engagement

Z2 Engagement

How Z2 engagements work – from CLD programme reviews to technology transfer and due diligence.

Read More
White Papers

White Papers

In-depth papers on cell line, media and upstream development topics – in preparation.

Read More
Scientist at a microscope in a biologics laboratory
Contact Us

Let's talk about your programme

Whether you are designing a CLD programme, stuck on an upstream process, preparing for technology transfer, or assessing a biologics asset before you commit.